Dr. Anup Ramani is one of the best Uro oncologist, Surgeon in Mumbai, India providing Robotic Surgery and Treatment for Prostate Cancer, Kidney Tumor Surgery/Stone Removal, Urinary Bladder Cancer and Adrenal Gland Treatment, Enlarged Prostate Surgery and treatment, Penis Cancer/Partial Penectomy/Robotic Pyeloplasty Surgery and Treatment.
Facebook-f X-twitter Youtube

Dr Anup Ramani @ Copyright 2024

How Does HPV Increase the Risk of Penile Cancer?

09 Oct
By Dr. Anup Ramani
Share At:
Google AI ChatGPT Grok Perplexity

Listening Article

AI Summary

HPV, especially high-risk types like HPV 16 and 18, is a leading cause of penile cancer. Persistent infection can trigger abnormal cell changes that progress to cancer over time, with risk influenced by immune response, lifestyle factors like smoking and poor hygiene, and conditions like phimosis. HPV vaccination significantly lowers risk, while early symptom recognition, timely diagnosis, and modern treatments — including robotic-assisted surgery — lead to better outcomes. Dr. Anup Ramani, a robotic uro-oncologist in Mumbai, offers evidence-based, organ-preserving penile cancer care.

Penile cancer is rare, but for men and families facing a diagnosis, understanding why it happened matters as much as knowing what comes next. One of the most significant, well-studied causes is the human papillomavirus (HPV). Research shows that HPV infection and penile cancer are closely linked, with certain high-risk HPV types responsible for a large share of cases worldwide.

This article explains how HPV infection develops, why specific strains raise cancer risk, the role of immunity and lifestyle, and how prevention, early diagnosis, and modern treatment — including robotic surgery — can improve outcomes.

How Does HPV Increase Penile Cancer Risk?

Direct Answer: High-risk HPV types can alter normal penile cells by interfering with genes that control cell growth. When HPV infection persists for years, these abnormal changes may progress from precancerous conditions to penile cancer.

 
Need More Information?
White Email Us Today!
 

Understanding HPV and Penile Cancer Risk

HPV is one of the most common sexually transmitted infections globally. Most infections clear on their own within one to two years, but persistent infection with certain high-risk HPV types can lead to abnormal cell changes. Over time, in a subset of men, these changes may progress to penile cancer.

Studies estimate that HPV DNA is detectable in roughly 30–50% of penile cancer cases, making HPV infection and penile cancer one of the most important relationships in urologic oncology. This doesn’t mean everyone with HPV develops cancer — most won’t — but persistent infection with specific strains meaningfully raises risk.

HPV Infection and Penile Cancer

HPV spreads through skin-to-skin genital contact, not just penetrative intercourse. Once the virus enters the skin or mucous membrane cells of the penis, it can:

  • Integrate into the host cell’s genetic material
  • Interfere with the normal genes that regulate cell growth and repair
  • Cause infected cells to divide abnormally and avoid natural cell death

When this disruption becomes persistent, it can lead to a precancerous condition called penile intraepithelial neoplasia (PeIN). Left undiagnosed or untreated, PeIN can, in some cases, progress into invasive penile cancer.

High-Risk HPV Types Linked to Penile Cancer

Not all HPV types carry the same risk. Doctors classify HPV strains as low-risk or high-risk based on their cancer-causing potential.

High-risk HPV types most strongly linked to penile cancer include:

  • HPV 16 — the single most common type found in HPV-related penile cancers
  • HPV 18 — associated with more aggressive tumor behavior
  • Other high-risk types such as HPV 31, 33, and 45, though less frequently implicated

These strains produce viral proteins (E6 and E7) that switch off the body’s natural tumor-suppressor genes. This is a central reason human papillomavirus and penile cancer are so closely studied — the mechanism mirrors how HPV drives cervical, anal, and oropharyngeal cancers in other parts of the body. In simple terms, these viral proteins interfere with the body’s natural ability to control abnormal cell growth.

Low-risk HPV types, such as HPV 6 and 11, more commonly cause genital warts and rarely lead to cancer.

Can HPV Cause Penile Cancer Without Symptoms?

Yes — this is one of the most important things patients should understand. HPV infection often has no visible symptoms, meaning a man can carry a high-risk strain for years without knowing it. Cancer-related changes may develop slowly, often over a decade or more, as the virus gradually disrupts normal cell control.

Because the early stages are frequently silent, routine self-checks matter. Any persistent skin change, discoloration, or thickening on the penis — even without pain — warrants prompt evaluation, since these can be the first visible sign of an underlying HPV-driven process.

Immune Response and HPV-Related Penile Cancer Risk

Not every man exposed to high-risk HPV develops penile cancer. The immune system plays a decisive role in clearing the virus before it causes lasting damage.

Factors that weaken immune surveillance and allow HPV to persist include:

  • Chronic immunosuppression — organ transplant recipients or long-term immunosuppressive therapy
  • HIV infection — reduced ability to clear HPV
  • Advancing age — immune response can decline over time
  • Chronic inflammation — ongoing irritation may support viral persistence

A healthy immune system generally clears HPV within 12–24 months. When the virus persists beyond this window, precancerous and cancerous risk rises.

Penile Cancer Risk Factors Beyond HPV

While HPV is a leading cause, it rarely acts alone. Several penile cancer risk factors often occur alongside HPV and amplify overall risk:

  • Phimosis (inability to retract the foreskin), which can trap moisture, smegma, and HPV particles against the skin
  • Poor genital hygiene, contributing to chronic irritation
  • Smoking, which introduces carcinogens that interact with HPV-damaged cells and impairs immune clearance
  • Multiple sexual partners or early sexual activity, increasing cumulative HPV exposure
  • Lack of circumcision, particularly when combined with phimosis and poor hygiene
  • Chronic penile inflammation or lichen sclerosus, an independent risk factor that can also coexist with HPV

Understanding these penile cancer causes together — rather than in isolation — helps explain why some men with HPV develop cancer while others do not.

HPV Vaccination and Penile Cancer Prevention

One of the most effective tools available today is HPV vaccination and penile cancer prevention strategy built around it. The HPV vaccine protects against the high-risk strains most strongly linked to genital and oropharyngeal cancers, including HPV 16 and 18.

Key points for patients and families:

  • Most effective when given before sexual activity begins, typically recommended for adolescents
  • Catch-up vaccination benefits young adults who missed the initial window
  • Reduces — but doesn’t eliminate — risk, so genital health awareness remains important
  • Vaccinating both males and females strengthens community-wide protection

Prevention After HPV Infection

For men already diagnosed with HPV, prevention shifts toward prevention after HPV infection — reducing the chance that the virus progresses toward precancerous or cancerous changes:

  • Routine self-examination for unusual lumps, sores, color changes, or persistent skin changes on the penis
  • Prompt treatment of phimosis or chronic inflammation
  • Smoking cessation
  • Regular follow-up with a urologist if abnormal cell changes (PeIN) have previously been identified
  • Practicing safer sex, including consistent condom use, which reduces (though does not eliminate) transmission risk

Penile Cancer Symptoms

Early detection significantly improves treatment outcomes. Common penile cancer symptoms include:

  • A growth, lump, or ulcer on the glans, foreskin, or shaft
  • Changes in skin color or thickening of the skin
  • Persistent discharge or foul odor
  • Bleeding not related to injury
  • Pain or discomfort, though early lesions are sometimes painless
  • Swelling or difficulty retracting the foreskin

Because early lesions can resemble minor irritation, any persistent penile skin change lasting more than a few weeks should be evaluated by a specialist promptly.

Penile Cancer Diagnosis

Accurate penile cancer diagnosis relies on a combination of clinical examination and targeted testing:

  • Physical examination to assess the lesion’s size, location, and characteristics
  • Biopsy to confirm cancer and determine its type and grade
  • HPV testing on tissue samples, which can help determine whether the tumor is HPV-driven
  • Imaging studies such as ultrasound, MRI, or CT scans to assess local invasion and check lymph node involvement
  • Lymph node evaluation, since penile cancer often spreads first to the inguinal (groin) lymph nodes

Accurate staging is essential, as it directly shapes the treatment plan.

Treatment Options for HPV-Related Penile Cancer

Treatment options for HPV-related cancer of the penis depend on tumor size, depth of invasion, grade, and lymph node involvement. Options include:

  • Topical therapies for early, non-invasive lesions (PeIN)
  • Laser therapy or local excision to preserve healthy tissue and function
  • Partial or total penectomy for advanced or deeply invasive tumors
  • Lymph node dissection, essential when cancer has spread to the groin
  • Chemotherapy and radiation, used before or after surgery, or for advanced disease
  • Robotic-assisted surgery, offering precise tumor removal and lymph node dissection with smaller incisions, less blood loss, and faster recovery than open surgery

Penile cancer surgery in India has advanced considerably, with several centers now offering robotic and minimally invasive techniques once available only in a handful of countries.

What Our Patients Are Saying

" Dr. Ramani was very professional in his approach. He spent a lot of time to discuss the problem and compassionately handled a very complicated case. He is always accessible and ready to go the extra mile to put the patient at ease. Highly recommended! "
Manish Maheswari
On Google

Penile Cancer Specialist in India

For patients seeking a penile cancer specialist in India, experience with both the medical and surgical complexity of HPV-related penile cancer is essential. Dr. Anup Ramani, a robotic uro-oncologist based in Mumbai, brings extensive experience in diagnosing and treating penile cancer using evidence-based, organ-preserving, and minimally invasive approaches wherever clinically appropriate.

As a uro oncology specialist in Mumbai, Dr. Ramani’s approach focuses on:

  • Precise, HPV-informed diagnostic evaluation
  • Organ-sparing surgical techniques when tumor characteristics allow
  • Robotic-assisted lymph node dissection to improve accuracy and reduce complications
  • Individualized treatment planning based on tumor stage and patient goals
  • Long-term follow-up care addressing both cancer surveillance and quality of life

Patients exploring penile cancer treatment in Mumbai benefit from advanced robotic technology paired with a philosophy centered on comfort, function preservation, and long-term outcomes — making Dr. Ramani a trusted choice among those seeking a penile cancer surgeon in Mumbai.

Long-Term Health After Penile Cancer Treatment

Recovery from penile cancer extends beyond surgery. Long-term considerations include:

  • Regular follow-up visits to monitor for recurrence, typically more frequent in the first two years
  • Psychological and emotional support, as changes in body image and sexual function are common concerns
  • Sexual health counseling, including discussion of function-preserving options where appropriate
  • Ongoing HPV awareness, since patients treated for one HPV-related cancer may have elevated risk for other HPV-associated cancers
  • Lifestyle modification, including smoking cessation and maintaining genital hygiene, to support long-term health

Family involvement during recovery plays an important role in a patient’s overall wellbeing and adjustment.

About Dr. Anup Ramani

Dr. Anup Ramani is a robotic uro-oncologist in Mumbai with extensive experience in diagnosing and treating HPV-related penile cancer. He offers evidence-based, organ-preserving care using advanced robotic and minimally invasive techniques, guiding patients through diagnosis, surgery, and long-term follow-up with a focus on both cancer control and quality of life. Patients across India seeking specialized penile cancer care trust his individualized, patient-first approach.

 
Call Now for Quick Support
White Call Now!
 

Conclusion

HPV plays a well-documented role in penile cancer, but persistent infection doesn’t have to lead to a diagnosis — awareness, vaccination, and timely evaluation make a real difference. With early detection and modern, evidence-based treatment, including minimally invasive and robotic-assisted options, outcomes continue to improve. Patients and families are encouraged to seek expert guidance early rather than waiting for symptoms to worsen.

Frequently Asked Questions About HPV and Penile Cancer Risk

Yes. Persistent infection with high-risk HPV types, especially HPV 16 and 18, is one of the leading known causes of penile cancer.

HPV 16 and 18 are the most strongly linked, with other high-risk types like HPV 31, 33, and 45 implicated less frequently.

No. Most HPV infections clear naturally within one to two years. Cancer risk rises only when infection with a high-risk strain persists over time.

The HPV vaccine significantly lowers risk by protecting against the high-risk strains most associated with penile and other genital cancers, though it does not eliminate risk entirely.

Early signs include a persistent lump, ulcer, skin discoloration, thickening, or discharge on the penis — often painless in the early stages.

Diagnosis involves physical examination, biopsy, HPV testing on tissue samples, and imaging to assess tumor spread and lymph node involvement.

Yes. Early-stage penile cancer often responds well to organ-preserving treatments such as topical therapy, laser treatment, or local excision, with high cure rates.

Any persistent penile skin change, lump, sore, or discharge lasting more than a few weeks should prompt an evaluation with a uro-oncology specialist without delay.

Recent Blogs

Dr. Anup Ramani is one of the best Uro oncologist, Surgeon in Mumbai, India providing Robotic Surgery and Treatment for Prostate Cancer, Kidney Tumor Surgery/Stone Removal, Urinary Bladder Cancer and Adrenal Gland Treatment, Enlarged Prostate Surgery and treatment, Penis Cancer/Partial Penectomy/Robotic Pyeloplasty Surgery and Treatment.

Best Uro-Oncological surgeon
Specialist in India for Robotic Surgery
MCh, DNB, MS, DNB
Dr. Anup Ramani

Facebook-f X-twitter Youtube Tumblr Pinterest

MENU

QUICK LINKS

CONTACT

Dr. Anup Ramani
Uro-Oncologist in India,
Best Robotic Surgeon for Uro Oncology Surgery

1407, One Lodha Place Next to World Towers Senapati Bapat Marg, Worli, Mumbai. 400013.

Dr Anup Ramani @ Copyright 2026 – Website Maintenance, SEO & GEO by Opal Infotech

PARTIAL PENECTOMY
  • Partial penectomy is done in cases where glans and distal penis is involved with carcinoma. 
  • Partial penectomy is a type of organ-preserving surgery. Preservation of sexual and micturational function depends on the surgical dissection and reconstruction of residual urethra.
Kidney Stone Removal
  • Patients who develop stones in the kidney or ureter, often experience severe pain.
  • This condition usually needs a procedure to remove the kidney stones.
  • This procedure is called ureteroscopy and is performed very commonly.
  • It does not require any cuts and hence it is painless.
  • The procedure is performed with an endoscope inserted through the penis under spinal anesthesia.
  • The scope is inserted through the penis into the kidney and stones are dissolved with a laser.
  • The procedure takes about 40-50 minutes. 
  • A catheter (urine pipe) is kept after the procedure to drain the bladder. A stent is kept in the kidney at the same time.
  • Patient is mobile and walking in the room the same evening.
  • Hospital stay is one night and patient is discharged the next day after removal of the catheter.
  • Patient has to come back after six weeks to remove the stent in the kidney.
  • Patients can resume office a week after surgery and heavy activities like running, weight lifting, a month after the procedure.
  • We offer fixed packages for this procedure which can be obtained by calling our helpline +91 9967666060.
  • Men with an enlarged prostate, which is a normal ageing changes, often experiencing difficulty passing urine. This condition usually needs a procedure to trim the prostate and relieve the blockage.
  • This procedure is called TURP and is performed very commonly.
  • It does not require any cuts and hence it is painless.
  • The procedure is performed with an endoscope inserted through the penis under spinal anaesthesia.
  • The overgrown prostate is dissolved with a laser bloodlessly.
  • The procedure takes about 40 minutes.
  • A catheter (urine pipe) is kept after the procedure to drain the bladder.
  • Patient is mobile and walking in the room the same evening.
  • Hospital stay is two nights and patient is discharged with the catheter, which is removed after 4 days.
  • Patients can resume office a week after surgery and heavy activities like running, weight lifting, a month after the procedure.
  • We offer fixed packages for this procedure which can be obtained by calling our helpline +91 9967666060.
ROBOTIC ADRENALECTOMY FOR ADRENAL GLAND TUMOUR

  • Robotic adrenalectomy is a sophisticated, complex surgery and it is very important that an experienced surgeon performs this surgery to avoid major complications.

  • Once the anesthesia is done, and patient positioned, three micro cuts (3mm each) are made in the patient’s abdomen.

  • The arms of the Da Vinci robot are connected to the cuts via ports (tubes).

  • Dr. Ramani then sits in the controlling console to perform the surgery.

  • On an average, a robotic adrenalectomy takes one hour.

  • The surgery is almost completely bloodless and there has never been any need to transfuse blood after surgery.

  • A urine catheter and bag to drain the bladder is inserted during surgery.

  • A tiny drain pipe may be inserted in the surgical side of the abdomen, connected to a bag.

  • Patient is kept nil-by-mouth the day of the surgery, with IV fluids. Sips of water are started the next day and solid food by day three.

  • The drain pipe, if kept, is removed in the room on day 2 after surgery.

  • The catheter is removed on day two after surgery.

  • Total hospital stay for robotic adrenalectomy is 4 nights (including night before surgery).

  • Post discharge, a doctor from the surgical team visits the patient at home/ hotel room once every day.

RETURN TO ACTIVITY

  • On the day of discharge, patient is totally self-sufficient. They are able to walk freely without any pain, dress themselves, shower, toilet and they do not need to hire any nurse or help at home. Almost all patients are back to work within 2 weeks of surgery.

  • Heavy activities like running, weight lifting can be resumed after a month

FOLLOW UP AFTER SURGERY

  • Follow up after an adrenalectomy is in the form of CT scans, once a year for 5 years.
    Local patients usually meet Dr. Ramani after two weeks to discuss report.

  • Outstation patients are counselled on a phone consultation.

ROBOTIC SURGERY FOR BLADDER CANCER
  • Dr. Ramani is one of the very few surgeons in India who has the expertise to perform a robotic surgery for bladder cancer, which includes removing the urinary bladder and reconstructing a new bladder robotically.
  • Robotic radical cystectomy is an extremely sophisticated, complex surgery and it is very important that an experienced surgeon performs this surgery to avoid major complications.
  • Once the anaesthesia is done, and patient positioned, six micro cuts (3mm each) are made in the patient’s abdomen.
  • The arms of the Da Vinci robot are connected to the cuts via ports (tubes).
  • Dr. Ramani then sits in the controlling console to perform the surgery.
  • On an average, a robotic radical cystectomy with an ileal conduit takes 3-4 hours.
  • The surgery is almost completely bloodless and there has never been any need to transfuse blood after surgery.
  • A urine catheter and bag to drain the new bladder is inserted during surgery.
  • Two tiny drain pipe in inserted in the surgical side of the abdomen, connected to a bag.
  • Patient is kept nil-by-mouth for 4 days after surgery with IV supplementation of patient’s daily requirements of calories, fats, carbohydrates, proteins and electrolytes.
  • The drain pipes are removed in the room on day 3-5 after surgery.
  • Total hospital stay for radical cystectomy is 8 nights (including night before surgery).
  • Post discharge, a doctor from the surgical team visits the patient at home/ hotel room once every day.
RETURN TO ACTIVITY
  • On the day of discharge, patient is totally self-sufficient. They are able to walk freely without any pain, dress themselves, shower, toilet and they do not need to hire any nurse or help at home.
  • Almost all patients are back to work within 6 weeks of surgery. Heavy activities like running, weight lifting can be resumed after two months.
FOLLOW UP AFTER SURGERY

  • Follow up after a radical a cystectomy is in the form of CT scans, once a year for 5 years.

  • Histopathology report: Local patients usually meet Dr. Ramani after two weeks to discuss report.

  • Outstation patients are counselled on a phone consult. Depending on the report, patient may or may not need chemotherapy after surgery.

  • If chemo is needed, patients may choose to get it done with a medical oncologist of their choice or avail the services of one of the four medical oncologists on our team.

ROBOTIC RADICAL/PARTIAL NEPHRECTOMY FOR KIDNEY CANCER
  • Robotic partial nephrectomy is a sophisticated, complex surgery and it is very important that an experienced surgeon performs this surgery to avoid major complications. Robotic radical (total) nephrectomy is
  • relatively easier but still requires significant experience to consistently deliver results.
  • Once the anaesthesia is done, and patient positioned, five micro cuts (3mm each) are made in the patient’s abdomen.
  • The arms of the Da Vinci robot are connected to the cuts via ports (tubes).
  • Dr. Ramani then sits in the controlling console to perform the surgery.
  • On an average, a robotic radical nephrectomy takes one hour and a robotic partial nephrectomy takes about an hour and half.
  • The surgery is almost completely bloodless and there has never been any need to transfuse blood after surgery.
  • A urine catheter and bag to drain the bladder is inserted during surgery.
  • A tiny drain pipe in inserted in the surgical side of the abdomen, connected to a bag.
  • Patient is kept nil-by-mouth the day of the surgery, with IV fluids. Sips of water are started the next day and solid food by day three.
  • The drain pipe is removed in the room on day 3 after surgery. The catheter is removed on day two after surgery.
  • Total hospital stay for radical/partial nephrectomy is 4 nights (including night before surgery).
  • Post discharge, a doctor from the surgical team visits the patient at home/ hotel room once every day.
RETURN TO ACTIVITY
  • On the day of discharge, patient is totally self- sufficient. 
  • They are able to walk freely without any pain, dress themselves, shower, toilet and they do not need to hire any nurse or help at home. 
  • Almost all patients are back to work within 2-3 weeks of surgery.
  • Heavy activities like running, weight lifting can be resumed after a month.
FOLLOW UP AFTER SURGERY
  • Follow up after a radical/partial Nephrectomy is in the form of CT scans, once a year for 5 years.
  • Local patients usually meet Dr. Ramani after two weeks to discuss report. 
  • Outstation patients are counselled on a phone consultation.